Results 1 to 10 of about 15,183 (185)

Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB. [PDF]

open access: yesJIMD Rep
ABSTRACT Mucopolysaccharidosis Type IV is a multisystem lysosomal storage disease characterized by severe skeletal dysplasia resulting from impaired degradation of the glycosaminoglycans keratan sulfate and chondroitin‐6‐sulfate. The condition is classified into Types A and B based on the underlying enzyme deficiency.
Wijnen M   +5 more
europepmc   +2 more sources

Romosozumab Versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: An Overview of Systematic Reviews With Direct and Indirect Meta-Analyses. [PDF]

open access: yesInt J Rheum Dis
ABSTRACT Aim To summarize the evidence of efficacy and safety of romosozumab compared to teriparatide for postmenopausal osteoporosis. Methods A literature search was performed in Medline, the Cochrane Library, CRD, and LILACS until November 2023. We included systematic reviews with meta‐analyses on the use of romosozumab compared to teriparatide in ...
Bandeira TFGS   +4 more
europepmc   +2 more sources

Teriparatide use in osteopenic patients undergoing single-level lumbar fusion associated with decreased 2-year revision rates [PDF]

open access: yesJournal of Craniovertebral Junction and Spine
Context: Low bone density is common among lumbar fusion patients and increases the risks of pseudarthrosis, hardware failure, and revision. Teriparatide improves bone mass and fusion in osteoporosis, but its benefit in osteopenia or normal bone remains ...
Mitchell K. Ng   +10 more
doaj   +2 more sources

Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan's National Claims Database. [PDF]

open access: yesClin Pharmacol Ther
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Maruyama H   +5 more
europepmc   +2 more sources

Is Teriparatide Superior in Treating Osteoporotic Vertebral Compression Fractures in Comparison to Bisphosphonates Treatment Alone: A 2-Year Retrospective Analysis [PDF]

open access: yesAsian Spine Journal, 2023
Study Design Retrospective cohort study. Purpose This study aimed to compare the efficacy of bisphosphonates and teriparatide in the management of osteoporotic vertebral compression fractures with regard to pain management, prevention of nonunion, and ...
Vishnu Vikraman Nair   +5 more
doaj   +1 more source

Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China

open access: yesFrontiers in Public Health, 2022
ObjectiveWe aimed to assess the cost-effectiveness of sequential teriparatide/zoledronic acid relative to zoledronic acid monotherapy for postmenopausal osteoporotic women in China.MethodsA previously validated Markov microsimulation model was updated to
Ruxu You   +7 more
doaj   +1 more source

The efficacy of teriparatide on lumbar spine bone mineral density, vertebral fracture incidence and pain in post-menopausal osteoporotic patients: A systematic review and meta-analysis

open access: yesBone Reports, 2020
Objective: Teriparatide has been increasingly utilized in the management of osteoporosis. The efficacy of low and high dose teriparatide on lumbar spine bone mineral density, vertebral fracture incidence and pain is unknown.
Shakib Akhter   +7 more
doaj   +1 more source

Effect of teriparatide on drug treatment of tuberculous spondylitis: an experimental study

open access: yesScientific Reports, 2022
Tuberculous spondylitis often develops catastrophic bone destruction with uncontrolled inflammation. Because anti-tuberculous drugs do not have a role in bone formation, a combination drug therapy with a bone anabolic agent could help in fracture ...
Subum Lee   +8 more
doaj   +1 more source

Comparison of the Efficacy of Romosozumab and Teriparatide for the Management of Osteoporotic Vertebral Compression Fractures [PDF]

open access: yesNeurospine, 2023
Objective Romosozumab is increasingly employed to manage osteoporosis. However, no studies have analyzed its effects on recent osteoporotic vertebral compression fractures (OVCFs).
Danbi Park   +7 more
doaj   +1 more source

The combined effect of parathyroid hormone (1–34) and whole-body vibration exercise on physical performance in OSteoporotic women (PaVOS study): a secondary analysis from a randomised controlled trial

open access: yesBMC Sports Science, Medicine and Rehabilitation, 2020
Background The aim of this study was to investigate the effect on physical performance of combining whole-body vibration exercise (WBV) with parathyroid hormone 1–34 (teriparatide) compared to teriparatide alone.
Ditte Beck Jepsen   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy